RESUMEN
BACKGROUND: Osgood-Schlatter disease (OSD) is the most common knee pain complaint among adolescents playing sports. Despite this, there remains controversy over the pathophysiology and whether specific anatomical characteristics are associated with OSD. PURPOSE: This study aimed to systematically and comprehensively characterize adolescents with OSD using magnetic resonance imaging (MRI) compared to pain-free controls, including both tissue abnormalities that may be associated with OSD, as well as anatomical characteristics. A secondary objective was to identify potential imaging biomarkers associated with pain. STUDY DESIGN: Cross-sectional study. METHODS: Adolescents with OSD and controls were recruited from 2020 to 2022. Following a clinical exam, demographics, pain, sports participation, and Tanner stage were collected. Knee MRI was conducted on the participants' most symptomatic knee (OSD) or the dominant leg (controls). RESULTS: Sixty-seven adolescents (46 with OSD and 30 controls) were included. 80% of participants with OSD had at least one tissue alteration compared to 54% of controls. Compared to controls, OSD had 36.3 (95%CI 4.5 to 289.7) higher odds of bony oedema at the tibial tuberosity, and 32.7 (95%CI 4.1 to 260.6) and 5.3 (95%CI 0.6 to 46.2) higher odds of bony oedema at the tibial epiphysis and metaphysis respectively. Participants with OSD also had higher odds of fluid/oedema at the patellar tendon (12.3 95%CI 3.3 to 46.6), and superficial infrapatellar bursitis (7.2). Participants with OSD had a more proximal tendon attachment (mean tibial attachment portion difference, -0.05, 95% CI: -0.1 to 0.0, p = 0.02), tendon thickness (proximal mean difference, -0.09, 95% CI: -0.4 to 0.2, p = 0.04; distal mean difference, -0.6, 95% CI: -0.9 to -0.2, p = 0.01). Those with bony/tendon oedema had 1.8 points (95% CI: 0.3 to 3.2) higher pain on palpation than those without (t = -2.5, df = 26.6, p = 0.019), but there was no difference between these groups in a functional single leg pain provocation. CONCLUSION: Adolescents with OSD present with tissue and structural abnormalities on MRI that differed from age-matched controls. The majority had findings in the patellar tendon and bone, which often co-occurred. However, a small proportion of OSD also presents without alterations. It appears these findings may be associated with clinical OSD-related pain on palpation of the tibial tuberosity. CLINICAL RELEVANCE: Our highlight the pathophysiology on imaging, which has implications for understanding the mechanism and treatment of OSD.
Asunto(s)
Biomarcadores , Articulación de la Rodilla , Imagen por Resonancia Magnética , Osteocondrosis , Humanos , Estudios Transversales , Adolescente , Masculino , Femenino , Osteocondrosis/diagnóstico por imagen , Articulación de la Rodilla/diagnóstico por imagen , Articulación de la Rodilla/patología , Estudios de Casos y Controles , Edema/diagnóstico por imagen , Tibia/diagnóstico por imagen , NiñoRESUMEN
UNLABELLED: We examined fat-independent associations of hormones with height and whole-body bone size and mineral content in 633 school children. IGF-1 and osteocalcin predict growth in height, while fat, osteocalcin, and in girls also, IGF-1 predict growth in bone size. Leptin and ghrelin are inversely associated with bone size in girls. INTRODUCTION: Obesity causes larger bone size and bone mass, but the role of hormones in this up-regulation of bone in obesity is not well elucidated. We examined longitudinal associations between baseline body fat mass (FM), and fat-independent fasting levels of ghrelin, adiponectin, leptin, insulin, insulin-like growth factor-I (IGF-1), osteocalcin, and intact parathyroid hormone, and subsequent changes in height and in whole-body height-adjusted bone area "BAheight" and size-adjusted bone mineral content "BMCsize" in 8- to 11-year-olds. METHODS: Analyses were carried out separately for boys (n = 325) and girls (n = 308) including data from baseline, 3 and 6 months from OPUS School Meal Study. RESULTS: In both sexes: gain in BAheight was positively associated with baseline FM (≥2.05 cm(2)/kg, both p ≤ 0.003). Furthermore, gain in height was positively associated with baseline IGF-1 (≥0.02 cm/ng/ml, p = 0.001) and osteocalcin (≥0.13 cm/ng/ml, p ≤ 0.009); and gain in BAheight was positively associated with baseline osteocalcin (≥0.35 cm(2)/ng/ml, p ≤ 0.019). In girls only, gain in BAheight was also positively associated with baseline IGF-1 (0.06 cm(2)/ng/ml, p = 0.017) and inversely associated with both baseline ghrelin (-0.01 cm(2)/pg/ml, p = 0.001) and leptin (-1.21 cm(2)/µg/ml, p = 0.005). In boys, gain in BMCsize was positively associated with osteocalcin (0.18 g/ng/ml, p = 0.030). CONCLUSIONS: This large longitudinal study suggests that in 8- to 11-year-old children, IGF-1 and osteocalcin predict growth in height, while FM, osteocalcin, and in girls also, IGF-1 predict growth in BAheight. Fat-independent inverse associations of leptin and ghrelin with BAheight in girls' are contrary to proposed growth-stimulating effects of leptin. Osteocalcin in boys predicts gain in BMCsize.
Asunto(s)
Adiposidad/fisiología , Estatura/fisiología , Densidad Ósea/fisiología , Desarrollo Infantil/fisiología , Hormonas/sangre , Antropometría/métodos , Desarrollo Óseo/fisiología , Niño , Fenómenos Fisiológicos Nutricionales Infantiles/fisiología , Femenino , Servicios de Alimentación , Ghrelina/sangre , Humanos , Insulina/sangre , Factor I del Crecimiento Similar a la Insulina/metabolismo , Leptina/sangre , Estudios Longitudinales , Almuerzo , Masculino , Osteocalcina/sangre , Instituciones Académicas , Caracteres Sexuales , Maduración Sexual/fisiologíaRESUMEN
BACKGROUND: Facilitatory and inhibitory conditioned pain modulation (CPM) responses are observed in healthy volunteers and chronic pain patients, but the clinical implications for phenotyping are unknown. This study aimed to subgroup and compare chronic knee pain patients according to their CPM responses. METHODS: This explorative, cross-sectional study included 127 patients with chronic knee pain (osteoarthritis or following total knee arthroplasty). Individual CPM responses were categorized as facilitatory (test stimuli pain intensity increased when conditioning stimuli were applied), as inhibitory (test stimuli pain intensity decreased) or as no change (defined as less than 5.3% change in pain intensity). Outcomes were clinical pain intensities, temporal summation, widespread pain, self-reported physical function, PainDETECT questionnaire and Pain Quality Assessment Scale. Data were analysed as comparisons between the inhibitory and the facilitatory groups and using multivariate linear regression models. RESULTS: Fifty-four patients had facilitatory CPM responses, 49 had inhibitory CPM responses, and 24 showed no change in CPM response. A between-group difference was observed for self-reported physical function, with the facilitatory CPM group reporting better function (54.4 vs. 46.0, p = 0.028) and the facilitatory CPM group reported more deep pain sensations (3.2 vs. 2.0, p = 0.021). The remaining outcomes showed no between-group differences. Higher clinical pain intensity and facilitated temporal summation were associated in the facilitated CPM group but not in the inhibitory CPM group. CONCLUSION: These explorative findings indicated that quantitative clinical and experimental differences exist between facilitatory or inhibitory CPM responses in a chronic knee pain patient population. Differences in patients' CPM responses should be further investigated to unravel possible clinical importance. SIGNIFICANCE: Our findings confirm that conditioned pain modulation consist of inhibitory and facilitatory responders among a patient population with chronic knee pain. This explorative study indicates that patients with either facilitatory or inhibitory conditioned pain modulation could exhibit differences in pain outcomes. Subgrouping of chronic pain patients depending on individual conditioned pain modulation responses could be considered in phenotyping patients prior to inclusion in clinical trials or used for personalizing the management regime.
Asunto(s)
Dolor Crónico , Osteoartritis de la Rodilla , Humanos , Estudios Transversales , Osteoartritis de la Rodilla/complicaciones , Osteoartritis de la Rodilla/tratamiento farmacológico , Dimensión del Dolor , Umbral del Dolor/fisiología , Estudios Multicéntricos como AsuntoRESUMEN
High gamma (HG) power changes during motor activity, especially at frequencies above 70 Hz, play an important role in functional cortical mapping and as control signals for BCI (brain-computer interface) applications. Most studies of HG activity have used ECoG (electrocorticography) which provides high-quality spatially localized signals, but is an invasive method. Recent studies have shown that non-invasive modalities such as EEG and MEG can also detect task-related HG power changes. We show here that a 27 channel EEG (electroencephalography) montage provides high-quality spatially localized signals non-invasively for HG frequencies ranging from 83 to 101 Hz. We used a generic head model, a weighted minimum norm least squares (MNLS) inverse method, and a self-paced finger movement paradigm. The use of an inverse method enables us to map the EEG onto a generic cortex model. We find the HG activity during the task to be well localized in the contralateral motor area. We find HG power increases prior to finger movement, with average latencies of 462 ms and 82 ms before EMG (electromyogram) onset. We also find significant phase-locking between contra- and ipsilateral motor areas over a similar HG frequency range; here the synchronization onset precedes the EMG by 400 ms. We also compare our results to ECoG data from a similar paradigm and find EEG mapping and ECoG in good agreement. Our findings demonstrate that mapped EEG provides information on two important parameters for functional mapping and BCI which are usually only found in HG of ECoG signals: spatially localized power increases and bihemispheric phase-locking.
Asunto(s)
Mapeo Encefálico/métodos , Electroencefalografía/métodos , Adulto , Interpretación Estadística de Datos , Electromiografía , Femenino , Lateralidad Funcional/fisiología , Humanos , Masculino , Persona de Mediana Edad , Modelos Anatómicos , Corteza Motora/fisiología , Adulto JovenRESUMEN
We present a novel method for detecting frequency-frequency coupling between the electrical output of cortical areas as measured by electrocorticography (ECoG), electroencephalography (EEG) and magnetoencephalography (MEG), the biphase-locking value (bPLV). Our method is an extension of the well known phase-locking value (PLV) and is specifically sensitive to non-linear interactions, i.e. quadratic phase coupling across frequencies. Due to its sensitivity to non-linear interactions, it is robust to spurious synchronization arising from linear crosstalk, which is an especially useful property when analyzing data recorded by EEG/MEG. We discuss the statistical properties of the bPLV, specifically the distribution of the bPLV under assumption of random phases between the signals of interest. We also compare the bPLV to the PLV for cortical interactions that are computed for simulated EEG/MEG data. These data were mapped to the cortex using an inverse solution. We demonstrate our method for event related ECoG data recorded from the motor cortex of an epileptic patient, who performed a cued finger movement task. We find highly significant, movement related increase of the bPLV between the alpha (12 Hz) and high gamma (77 Hz) band in a pre-motor area, coupling to high gamma at 89 Hz in the motor cortex.
Asunto(s)
Encéfalo/fisiología , Electroencefalografía , Magnetoencefalografía , Dinámicas no Lineales , Procesamiento de Señales Asistido por Computador , Sincronización Cortical/métodos , HumanosRESUMEN
During the process of phagocytosis, polymorphonuclear leukocytes (PMN) release lysosomal enzymes into the extracellular medium. When the antibiotic cytochalasin B (CB) is present in the incubation medium along with phagocytable particles, enhanced recovery of enzyme activities from the incubation medium has been observed. These findings have led to the interpretation that CB enhances lysosomal enzyme release. Our results contradict this interpretation. The lysosomal enzymes acid phosphatase and beta-galactosidase are unstable after they are released from cells. During the first 5-15 min of phagocytosis, significant amounts of both acid phosphatase and beta-galactosidase can be recovered from the extracellular medium. After this, the recovery of enzyme from the medium declines, presumably because the rate of loss of lysosomal enzyme activity exceeds the rate of release at later time periods. In the presence of CB, the appearance of lysosomal enzymes in the extracellular medium of cells exposed to zymosan is retarded for 5-10 min, after which it begins and then continues for approximately 20 min. At the end of a 30-min incubation period, therefore, in the absence of CB, extracellular levels of lysosomal enzymes (especially those which are unstable) are declining toward low levels while, in the presence of CB, extracellular enzyme levels are continuing to rise. We also measured the lysosomal enzyme remaining within cells after exposure to zymosan. CB retarded the disappearance of enzyme from cells and resulted in significantly less total cell enzyme loss. Thus, in the presence of CB, a greater proportion of the lysosomal enzyme lost from cells is recovered in the extracellular medium. In contrast to the previous conclusions that CB enhances lysosomal enzyme release, our results indicate that CB delays and decreases the zymosan-stimulated release of lysosomal enzymes from PMN. Since CB inhibits phagocytosis by PMN, our results indicate that the antibiotic modifies the mechanism of release of lysosomal enzymes, resulting in zymosan stimulation of their release independently of phagocytosis.
Asunto(s)
Citocalasina B/farmacología , Lisosomas/enzimología , Neutrófilos/enzimología , Fagocitosis , Zimosan/farmacología , Fosfatasa Ácida/metabolismo , Galactosidasas/metabolismo , Glucuronidasa/metabolismo , Humanos , Masculino , Factores de TiempoRESUMEN
Certain gouty subjects with excessive de novo purine synthesis are deficient in hypoxanthineguanine phosphoribosyltransferase (HG-PRTase [EC 2.4.2.8]). The mechanism of accelerated uric acid formation in these patients was explored by measuring the incorporation of glycine-(14)C into various urinary purine bases of normal and enzyme-deficient subjects during treatment with the xanthine oxidase inhibitor, allopurinol. In the presence of normal HG-PRTase activity, allopurinol reduced purine biosynthesis as demonstrated by diminished excretion of total urinary purine or by reduction of glycine-(14)C incorporation into hypoxanthine, xanthine, and uric acid to less than one-half of control values. A boy with the Lesch-Nyhan syndrome was resistant to this effect of allopurinol while a patient with 12.5% of normal enzyme activity had an equivocal response. Three patients with normal HG-PRTase activity had a mean molar ratio of hypoxanthine to xanthine in the urine of 0.28, whereas two subjects who were deficient in HG-PRTase had reversal of this ratio (1.01 and 1.04). The patterns of (14)C-labeling observed in HG-PRTase deficiency reflected the role of hypoxanthine as precursor of xanthine. The data indicate that excessive uric acid in HG-PRTase deficiency is derived from hypoxanthine which is insufficiently reutilized and, as a consequence thereof, catabolized inordinately to uric acid. The data provide evidence for cyclic interconversion of adenine and hypoxanthine derivatives. Cleavage of inosinic acid to hypoxanthine via inosine does not contribute significantly to the formation of uric acid in either normal man or in patients with HG-PRTase deficiency.HG-PRTase was not completely absent in red blood cells from a boy with the Lesch-Nyhan syndrome; with hypoxanthine as substrate, the activity in erythrocyte hemolysates was 0.64% of normal values.
Asunto(s)
Enfermedades Carenciales/metabolismo , Purinas/biosíntesis , Transferasas/metabolismo , Adulto , Alopurinol/administración & dosificación , Atetosis/metabolismo , Isótopos de Carbono , Niño , Corea/metabolismo , Conducta Compulsiva , Glicina/metabolismo , Gota/metabolismo , Guanina/metabolismo , Humanos , Hipoxantinas/metabolismo , Inositol/metabolismo , Discapacidad Intelectual/metabolismo , Errores Innatos del Metabolismo/genética , Nucleósidos/metabolismo , Purinas/metabolismo , Automutilación/metabolismo , Ácido Úrico/biosíntesis , Ácido Úrico/sangreRESUMEN
BACKGROUND/OBJECTIVES: We previously found that the OPUS School Meal Study improved reading and increased errors related to inattention and impulsivity. This study explored whether the cognitive effects differed according to gender, household education and reading proficiency at baseline. SUBJECTS/METHODS: This is a cluster-randomised cross-over trial comparing Nordic school meals with packed lunch from home (control) for 3 months each among 834 children aged 8 to 11 years. At baseline and at the end of each dietary period, we assessed children's performance in reading, mathematics and the d2-test of attention. Interactions were evaluated using mixed models. Analyses included 739 children. RESULTS: At baseline, boys and children from households without academic education were poorer readers and had a higher d2-error%. Effects on dietary intake were similar in subgroups. However, the effect of the intervention on test outcomes was stronger in boys, in children from households with academic education and in children with normal/good baseline reading proficiency. Overall, this resulted in increased socioeconomic inequality in reading performance and reduced inequality in impulsivity. Contrary to this, the gender difference decreased in reading and increased in impulsivity. Finally, the gap between poor and normal/good readers was increased in reading and decreased for d2-error%. CONCLUSIONS: The effects of healthy school meals on reading, impulsivity and inattention were modified by gender, household education and baseline reading proficiency. The differential effects might be related to environmental aspects of the intervention and deserves to be investigated further in future school meal trials.
Asunto(s)
Cognición/fisiología , Composición Familiar , Servicios de Alimentación , Instituciones Académicas , Niño , Fenómenos Fisiológicos Nutricionales Infantiles , Estudios Cruzados , Dinamarca , Evaluación Educacional , Femenino , Humanos , Masculino , Estado Nutricional , Factores Sexuales , Resultado del TratamientoRESUMEN
Synovial fluid from 33 patients with inflammatory arthritis was examined with a polarized light microscope (PLM) and an atomic force microscope (AFM). Two samples were imaged with a transmission electron microscope (TEM) to determine calcium/phosphate ratios and identify microcrystals of calcium pyrophosphate dihydrate and octacalcium phosphate. Additional correlative x-ray diffraction studies were performed on several samples including purified hydroxyapatite and sodium chloride crystals. Monosodium urate, calcium pyrophosphate dihydrate, hydroxyapatite, octacalcium phosphate, and cholesterol crystals were identified with AFM. AFM images of these microcrystals revealed detailed surface topology, including lattice parameters and structural irregularities at the crystals' surface. These features were consistent with those obtained by TEM and x-ray diffraction studies. In addition, AFM images revealed that some specimens contained microcrystals that were undetected by PLM and/or TEM. These results suggest that AFM may provide a simple yet powerful technique for the detection of microcrystals in synovial fluid taken from patients with crystal-induced arthritis.
Asunto(s)
Fosfatos de Calcio/análisis , Líquido Sinovial/química , Sinovitis/metabolismo , Artritis/fisiopatología , Pirofosfato de Calcio/análisis , Cristalización , Durapatita/análisis , Humanos , Microscopía de Fuerza Atómica/métodos , Microscopía de Polarización/métodos , Recurrencia , Sinovitis/etiología , Ácido Úrico/análisisAsunto(s)
Indoles/farmacología , Leucocitos/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Zimosan/farmacología , Isótopos de Carbono , Citocalasina B/farmacología , Femenino , Glucosa/metabolismo , Glucuronidasa/metabolismo , Humanos , Inulina/metabolismo , Lactatos/biosíntesis , Leucocitos/enzimología , Leucocitos/metabolismo , Métodos , Oxidación-Reducción , Estimulación Química , Factores de TiempoRESUMEN
The uricosuric response to 80 mg of micronized Benzbromarone was employed to assess the renal tubular secretory site for uric acid in patients with primary gout. Since Benzbromarone selectively inhibits tubular reabsorption of secreted urate, the maximum uricosuria induced by this drug can be equated with the minimal secretory rate. Furthermore, a significant relationship was noted in normal controls between urate secretion and the plasma urate concentration (r = 0.956, p less than 0.005). Using the Benzbromarone response as a measure of tubular secretion, gouty patients with normal production hyperuricemia had a significantly lower secretory rate by comparison to patients with overproduction of uric acid. These data indicate that in patients with primary normal production hyperuricemia, the renal tubular defect is related to a decreased secretory response for a given plasma concentration of uric acid.
Asunto(s)
Túbulos Renales/metabolismo , Ácido Úrico/orina , Adulto , Benzbromarona/farmacología , Femenino , Tasa de Filtración Glomerular/efectos de los fármacos , Humanos , Túbulos Renales/efectos de los fármacos , Ácido Úrico/sangre , Ácido Úrico/metabolismoRESUMEN
OBJECTIVE: To compare the effect of dark and milk chocolate on appetite sensations and energy intake at an ad libitum test meal in healthy, normal-weight men. SUBJECTS/METHODS: A total of 16 young, healthy, normal-weight men participated in a randomized, crossover study. Test meals were 100 g of either milk (2285 kJ) or dark chocolate (2502 kJ). Visual-analogue scales were used to record appetite sensations before and after the test meal was consumed and subsequently every 30 min for 5 h. An ad libitum meal was served 2 h after the test meal had been consumed. RESULTS: The participants felt more satiated, less hungry, and had lower ratings of prospective food consumption after consumption of the dark chocolate than after the milk chocolate. Ratings of the desire to eat something sweet, fatty or savoury were all lower after consumption of the dark chocolate. Energy intake at the ad libitum meal was 17% lower after consumption of the dark chocolate than after the milk chocolate (P=0.002). If the energy provided by the chocolate is included in the calculation, the energy intake after consumption of the dark chocolate was still 8% lower than after the milk chocolate (P=0.01). The dark chocolate load resulted in an overall energy difference of -584 kJ (95% confidence interval (-1027;-141)) during the test period. CONCLUSION: In the present study, dark chocolate promotes satiety, lowers the desire to eat something sweet, and suppresses energy intake compared with milk chocolate.
Asunto(s)
Eritrocitos/enzimología , NADH NADPH Oxidorreductasas/sangre , Radioisótopos de Carbono , Cationes Bivalentes , Cromatografía , Cromatografía DEAE-Celulosa , Cromatografía por Intercambio Iónico , Cromatografía en Capa Delgada , Cobre , Nucleótidos de Guanina , Hemólisis , Humanos , Concentración de Iones de Hidrógeno , Hidroxiapatitas , Cinética , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , NADH NADPH Oxidorreductasas/aislamiento & purificación , Nucleótidos de Purina/farmacología , Espectrofotometría Ultravioleta , Compuestos de Sulfhidrilo/farmacología , Reactivos de Sulfhidrilo/farmacología , Temperatura , Factores de Tiempo , XantinasAsunto(s)
Hipoxantinas/orina , Errores Innatos del Metabolismo , Ácido Úrico/sangre , Xantinas/orina , Adulto , Dietoterapia , Humanos , Masculino , Xantinas/metabolismoRESUMEN
Using coherent x-ray speckle metrology, we have measured the influence of disorder on major loop return point memory (RPM) and complementary point memory (CPM) for a series of perpendicular anisotropy Co/Pt multilayer films. In the low disorder limit, the domain structures show no memory with field cycling--no RPM and no CPM. With increasing disorder, we observe the onset and the saturation of both the RPM and the CPM. These results provide the first direct ensemble-sensitive experimental study of the effects of varying disorder on microscopic magnetic memory and are compared against the predictions of existing theories.
RESUMEN
Bidirectional renal urate tranport was studied in both control and gouty subjects. 99.3% of filtered urate undergoes reabsorption as assessed by pyrazinamide suppression of urate secretion. The maximum uricosuric response to benzbromarone, equated with the minimum secretory rate, amounted to 50% of the filtered load in normal persons and was lower in gouty normoproducers. Since benzbromarone selectively inhibits reabsorption of secreted urate, the difference between secreted and excreted uric acid becomes a valid measure of urate reabsorption distal to the secretory site and amounts to 80% of the secreted load in both groups. These data conform to a 4-component model of renal urate handling in man.
Asunto(s)
Gota/metabolismo , Riñón/metabolismo , Ácido Úrico/metabolismo , Absorción , Benzbromarona/farmacología , Proteínas Sanguíneas , Femenino , Humanos , Técnicas In Vitro , Túbulos Renales/efectos de los fármacos , Túbulos Renales/metabolismo , Masculino , Modelos Biológicos , Unión Proteica , Pirazinamida/farmacología , Tasa de Secreción/efectos de los fármacos , TemperaturaRESUMEN
A 26-year-old woman was found to have an abnormally sensitive excretory response to a rise in plasma urate with a markedly increased ratio of uric acid to creatinine clearance (exceeding 35%). Uric acid was studied before and after administration of pyrazinamide and benzbromarone. In the presence of pyrazinamide urinary uric acid decreased markedly just as in normal subjects. The uricosuric response to benzbromarone was reduced. No other renal tubular or metabolic abnormalities were found. It appears that the abnormality is related to an isolated defect in postsecretory reabsorption of urate.
Asunto(s)
Enfermedades Metabólicas/metabolismo , Ácido Úrico/metabolismo , Absorción , Adulto , Benzbromarona , Femenino , Humanos , Enfermedades Metabólicas/sangre , Enfermedades Metabólicas/orina , Pirazinamida , Ácido Úrico/sangre , Ácido Úrico/orinaRESUMEN
The origin of uric acid, metabolic pathways of purine metabolism and the disposition of uric acid in normal man are reviewed. Two thirds of the uric acid is normally excreted through the kidney while one third gains entrance to the gut where it undergoes uricolysis. The pathogenesis of hyperuricemia in primary and secondary gout is discussed. Increased production or decreased excretion of uric acid are the two principal mechanisms of hyperuricemia. The known biochemical defects associated with primary overproduction gout are outlined. Extrarenal uricolysis assumes a greater role when the renal excretion of uric acid is compromised.